BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6225718)

  • 21. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
    Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
    Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of GM2 activator protein with glycosphingolipids.
    Hama Y; Li YT; Li SC
    J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].
    Hirabayashi Y; Li YT; Li SC
    Seikagaku; 1983; 55(1):1-13. PubMed ID: 6405000
    [No Abstract]   [Full Text] [Related]  

  • 24. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
    Meier EM; Schwarzmann G; Fürst W; Sandhoff K
    J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.
    Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

  • 28. Purification and properties of the hexosaminidase A-activating protein from human liver.
    Hechtman P; LeBlanc D
    Biochem J; 1977 Dec; 167(3):693-701. PubMed ID: 603630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synopsis: gangliosidoses.
    Schwab ME; Vassella F
    Neuropediatrics; 1984 Sep; 15 Suppl():107-9. PubMed ID: 6100793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the presence of two separate protein activators for the enzymic hydrolysis of GM1 and GM2 gangliosides.
    Li SC; Nakamura T; Ogamo A; Li YT
    J Biol Chem; 1979 Nov; 254(21):10592-5. PubMed ID: 115863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biochemical basis of gangliosidoses.
    Sandhoff K; Conzelmann E
    Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A; Holding J; Carey WF
    Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
    Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
    J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
    Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
    Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2.
    Hasilik A; von Figura K; Conzelmann E; Nehrkorn H; Sandhoff K
    Eur J Biochem; 1982 Jul; 125(2):317-21. PubMed ID: 6214395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein activators for the hydrolysis of GM1 and GM2 gangliosides.
    Li SC; Li YT
    Methods Enzymol; 1982; 83():588-95. PubMed ID: 6808306
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A GM2-specific beta-hexosaminidase from the roe of striped mullet (Mugil cephalus).
    DeGasperi R; Li SC; Li YT
    J Biol Chem; 1988 Jan; 263(3):1325-8. PubMed ID: 2961751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids.
    Werth N; Schuette CG; Wilkening G; Lemm T; Sandhoff K
    J Biol Chem; 2001 Apr; 276(16):12685-90. PubMed ID: 11278374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.